Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14 A SCHEDULE 14 A INFORMATION Proxy Statement Pursuant to Section 14 of the Securities Exchange Act of ...

With respect to their college hoops brethren, these football teams are destined for playoff madness next season.

During the meeting, stakeholders, including civil society organisations (CSOs) and the private sector, raised concerns about ...

With respect to their college hoops brethren, these football teams are destined for playoff madness next season.

Gain insights from ClearSign's Q4 2024 earnings call: record revenue growth, innovative product launches, strategic industry partnerships, and future plans.

Acting SEC Chair Mark T. Uyeda outlined potential regulatory changes to make IPOs more attractive and to scale public company disclosures at ...

Nine Republicans voted against their House speaker on proxy voting for new parents—causing him to abandon all plans for the ...

Q4 2024 Earnings Call Transcript March 31, 2025 Rani Therapeutics Holdings, Inc. misses on earnings expectations. Reported ...

Announced preclinical data demonstrating the bioequivalence of RT-114, a GLP-1/GLP-2 dual agonist (PG-102) delivered orally via the RaniPill® ...

The announcement of the Committee, which is comprised of 10 athletics directors (two from each autonomy conference) as well as legal and compliance administrators from the autonomy conferences and the ...

Q4 2024 Earnings Conference Call March 31, 2025 8:00 AM ETCompany ParticipantsRajiv De Silva - CEODomenic Della Penna - ...